Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer | Patent Number 10849888

US 10849888 B2
Application Number16033432
Publication NumberUS 20180318277 A1
Pendency2 years, 4 months, 23 days
Filled DateJul 12, 2018
Priority DateSep 26, 2012
Publication DateNov 8, 2018
Expiration DateSep 25, 2032
Inventor/ApplicantsIsan Chen
ExaminesHUI, SAN MING R
Art Unit1627
Technology Center1600
Assignments
Johnson & Johnson
Current
Aragon Pharmaceuticals Inc.Johnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.